An integrative network analysis framework for identifying molecular functions in complex disorders examining major depressive disorder as a test case
Abstract In addition to the psychological depressive phenotype, major depressive disorder (MDD) patients are also associated with underlying immune dysregulation that correlates with metabolic syndrome prevalent in depressive patients. A robust integrative analysis of biological pathways underlying...
Enregistré dans:
Auteurs principaux: | Anup Mammen Oommen, Stephen Cunningham, Páraic S. O’Súilleabháin, Brian M. Hughes, Lokesh Joshi |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7eae96b9cf37442c9578d13b6926dd7a |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Desvenlafaxine in the treatment of major depressive disorder
par: Maria Teresa C Lourenco1, et autres
Publié: (2009) -
Gene expression-based biological test for major depressive disorder: an advanced study
par: Watanabe S, et autres
Publié: (2017) -
Identifying predictive clinical characteristics of the treatment efficacy of mirtazapine monotherapy for major depressive disorder
par: Tsutsumi T, et autres
Publié: (2016) -
Identifying factors associated with the hospital readmission rate among patients with major depressive disorder
par: Sharareh Parami, et autres
Publié: (2021) -
Plasma proteomic data in bipolar II disorders and major depressive disorders
par: Hyunju Lee, et autres
Publié: (2021)